11,254
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Thyroid antibodies: which, why, when and who?

Pages 665-669 | Published online: 10 Jan 2014

References

  • McLachlan SM, Rapoport B. The molecular biology of thyroid peroxidase: cloning, expression, and role as autoantigen in autoimmune thyroid disease. Endocr. Rev.13, 192–206 (1992).
  • Rapoport B, McLachlan SM. Thyroid autoimmunity. J. Clin. Invest.108, 1253–1259 (2001).
  • Khoury EL, Hammond L, Bottazzo GF, Doniach D. Presence of the organ-specific "microsomal" autoantigen on the surface of human thyroid cells in culture: its involvement in complement-mediated cytotoxicity. Clin. Exp. Immunol.45, 316–328 (1981).
  • Jaume JC, Guo J, Pauls DL et al. Evidence for genetic transmission of thyroid peroxidase autoantibody epitopic “fingerprints”. J. Clin. Endocrinol. Metab.84, 1424–1431 (1999).
  • Dunn JT, Ray SC. Variations in the structure of thyroglobulins from normal and goitrous human thyroids. J. Clin. Endocrinol. Metab.47, 861–869 (1978).
  • Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM. The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev.19, 673–716 (1998).
  • Tahara K, Ishikawa N, Yamamoto K et al. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Thyroid7, 867–877 (1997).
  • Brix T, Kyvik KO, Hegedüs L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrinol. Metab.85, 536–539 (2000).
  • Brix TH, Kyvik KO, Christensen K, Hegedüs L. Evidence for a major role of heredity in Graves’ disease: a population-based study of two Danish twin cohorts. J. Clin. Endocrinol. Metab.86, 930–934 (2001).
  • Brix TH, Kyvik KO, Hegedüs L. What is the evidence of genetic factors in the etiology of Graves’ disease? A brief review. Thyroid8, 727–734 (1998).
  • Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr. Rev.24, 694–717 (2003).
  • Vanderpump MP, Tunbridge WM, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol.43, 55–68 (1995).
  • Cooper DS. Subclinical hypothyroidism N. Engl. J. Med.345, 260–265 (2001).
  • Surks MI, Ortiz E, Daniels GH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA291, 228–238 (2004).
  • Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism: the Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology. Br. Med. J.313, 539–544 (1996).
  • American Association of Clinical Endocrinologists. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr. Pract.8, 457–469 (2002).
  • Singer PA, Cooper DS, Levy EG, Ladenson PW, Braverman LE, Daniels G. Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA273, 808–812 (1995).
  • Spencer CA. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J. Clin. Endocrinol. Metab.89, 3702–3704 (2004).
  • Feldt-Rasmussen U, Hoier-Madsen M, Bech K et al. Anti-thyroid peroxidase antibodies in thyroid disorders and non-thyroid autoimmune diseases. Autoimmunity9, 245–254 (1991).
  • Demers LM, Spencer CA. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin. Endocrinol.58, 138–140 (2003).
  • Hjiyiannakis P, Mundy J, Harmer C. Thyroglobulin antibodies in differentiated thyroid cancer. Clin. Oncol. (R. Coll. Radiol.)11, 240–244 (1999).
  • Chiovato L, Latrofa F, Braverman LE et al. Disappearance of humoral thyroid autoimmunity after complete removal of thyroid antigens. Ann. Intern. Med.139, 346–351 (2003).
  • Baloch Z, Carayon P, Conte-Devolx B et al. (Guidelines Committee, National Academy of Clinical Biochemistry.) Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid13, 3–126 (2003).
  • Feldt-Rasmussen U. Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin and thyrotropin receptor. Clin. Chem.42, 160–163 (1996).
  • Khoo DH, Ho SC, Seah LL et al. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid9, 1175–1180 (1999).
  • Saravanan P, Dayan CM. Thyroid autoantibodies. Endocrinol. Metab. Clin. North Am.30, 315–337 (2001).
  • Costagliola S, Morgenthaler NG, Hoermann R et al. Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J. Clin. Endocrinol. Metab.84, 90–97 (1999).
  • Kumar H, Daykin J, Betteridge J, Holder R, Sheppard MC, Franklyn JA. Prevalence and clinical usefulness of thyroid antibodies in different disease states of the thyroid. Clin. Endocrinol.50, 679–680 (1999).
  • Guerin B, Vautier V, Boin-Gay V, Estrade G, Choulot JJ, Doireau V. Severe neonatal hyperthyroidism which reveals a maternal Graves' disease. Ann. Endocrinol.65, 125–130 (2004).
  • Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur. J. Endocrinol.139, 584–586 (1998).
  • Johnston AM, Eagles JM. Lithium-associated clinical hypothyroidism. Prevalence and risk factors. Br. J. Psychiatry175, 336–339 (1999).
  • Daniels GH. Amiodarone-induced thyrotoxicosis. J. Clin. Endocrinol. Metab.86, 3–8 (2001).
  • Irvine WJ, Davies SH, Teitelbaum S, Delamore IW, Williams AW. The clinical and pathological significance of gastric parietal cell antibody. Ann. NY Acad. Sci.124, 657–691 (1965).
  • Doniach D, Roitt IM, Taylor KB. Autoimmune phenomena in pernicious anemia. Serological overlap with thyroiditis, thyrotoxicosis, and systemic lupus erythematosus. Br. Med. J.5342, 134–139 (1963).
  • Tudhope GR, Wilson GM. Deficiency of vitamin B12 in hypothyroidism. Lancet1, 703–706 (1962).
  • Jenkins RC, Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid12, 975–986 (2002).
  • Berry P. Audit of investigation of subclinical hypothyroidism in Scottish laboratories. Ann. Clin. Biochem.39, 26–33 (2002).
  • Briston P, Sinclair D. Antibodies to thyroid peroxidase (TPOAb) in serum from patients with slightly raised thyrotropin (TSH) levels. Clin. Lab.50, 383–386 (2004).
  • Lock RJ, Marden NA, Kemp HJ, Thomas PH, Goldie DJ, Gompels MM. Subclinical hypothyroidism: a comparison of strategies to achieve adherence to treatment guidelines. Ann. Clin. Biochem.41, 197–200 (2004).

Website

  • Spencer CA. Assay of thyroid hormones and related substances www.thyroidmanager.org/FunctionTests/assay-text.htm

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.